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Abstract
The cell adhesion molecule L1 (L1-CAM) plays important functional roles in the developing and adult nervous systems. Here we show
that peripheral nerve injury induced dynamic post-transcriptional alteration of L1-CAM in the rat dorsal root ganglia (DRGs) and spinal
cord. Sciatic nerve transection (SCNT) changed the expression of L1-CAM protein but not L1-CAM mRNA. In DRGs, SCNT induced
accumulation of the L1-CAM into the surface of somata, which resulted in the formation of immunoreactive ring structures in a
number of unmyelinated C-ﬁber neurons. These neurons with L1-CAM-immunoreactive ring structures were heavily colocalized with
phosphorylated p38 MAPK. Western blot analysis revealed the increase of full-length L1-CAM and decrease of fragments of L1-CAM
after SCNT in DRGs. Following SCNT, L1-CAM-immunoreactive proﬁles in the dorsal horn showed an increase mainly in pre-
synaptic areas of laminae I–II with a delayed onset and colocalized with growth-associated protein 43. In contrast to DRGs, SCNT
increased the proteolytic 80-kDa fragment of L1-CAM and decreased full-length L1-CAM in the spinal cord. The intrathecal injection
of L1-CAM antibody for the extracellular domain of L1-CAM inhibited activation of p38 MAPK and emergence of ring structures of
L1-CAM immunoreactivity in injured DRG neurons. Moreover, inhibition of extracellular L1-CAM binding by intrathecal administration
of antibody suppressed the mechanical allodynia and thermal hyperalgesia induced by partial SCNT. Collectively, these data suggest
that the modiﬁcation of L1-CAM in nociceptive pathways might be an important pathomechanism of neuropathic pain.
Introduction
Peripheral nerve injury may lead to neuropathic pain syndromes
characterized by both spontaneous and evoked painful sensations. It
has been hypothesized that peripheral nerve injury alters the
neurochemical features of dorsal root ganglia (DRGs) neurons
(‘phenotypic change’) in both damaged and intact neurons, and
results in disordered sensory processing (Zimmermann, 2001; Luo
et al., 2002; Obata et al., 2003, 2004a,b; Ji & Strichartz, 2004;
Yamanaka et al., 2004). These long-term changes evoked by
peripheral nerve injury may lead to the reorganization of dorsal horn
circuits and a number of neuroplastic changes. These changes in
DRGs and spinal dorsal horn are believed to contribute to the
development and maintenance of neuropathic pain (Coderre, 1993;
Woolf & Doubell, 1994). The molecular mechanism of how these
plastic changes in DRGs and dorsal horn are involved in neuropathic
pain states has been a very important theme in pain research.
The neural cell adhesion molecule, cell adhesion molecule L1
(L1-CAM), is a member of the immunoglobulin superfamily and is
known to be critical for the development of the nervous system. L1-
CAMisinvolvedinanumberofprocesses,includingneuriteoutgrowth
(Lemmon et al., 1989; Williams et al., 1992, 1994), axon fasciculation
(Kunz et al., 1998; Wiencken-Barger et al., 2004), myelination (Haney
et al., 1999) and regeneration in the adult nervous system (Martini &
Schachner, 1988; Dihne et al., 2003). L1-CAM binds to a variety of
extracellular partners including L1-CAM itself, other members of the
immunoglobulin superfamily (Tag1⁄axonin-1 and contactin⁄F3⁄F11)
(Kuhn et al., 1991; Brummendorf et al., 1993; Buchstalleret al., 1996),
integrins (Ruppert et al., 1995; Montgomery et al., 1996; Thelen et al.,
2002) and other extracellular matrix components. Extracellular inter-
actions of L1-CAM with these binding partners have been demonstra-
ted to have physiological signiﬁcance and lead to the activation of
intracellular signaling cascades, such as ﬁbroblast growth factor
receptor 1, src, phosphatidylinositol-3¢ kinase and MAPK systems
(Schaefer et al., 1999; Doherty et al., 2000; Loers et al., 2005). In
addition, L1-CAM can participate not only in the development or
regeneration ofthenervous systembutalsointheregulationofsynaptic
plasticity accompanied with circuitry changes in adult rodent brain
(Luthl et al., 1994; Saghatelyan et al., 2004). In the nociceptive
pathway, L1-CAM is expressed in primary afferent neurons and also in
the dorsal horn of spinal cord (Haney et al., 1999; Nakai & Kamiguchi,
2002; Runyan et al., 2005). However, it is not clear how L1-CAM in
DRGs and dorsal horn is affected by peripheral nerve injury and
whether L1-CAM has a role in the neuropathic pain mechanism. We
now show that L1-CAM shows dynamic post-transcriptional modiﬁ-
cation in DRGs and spinal cord after peripheral nerve injury and is
involved in neuropathic pain behaviors by activating intracellular
signaling cascades in nociceptive pathways.
Materials and methods
Animal treatment
Male Sprague Dawley rats weighing 200–250 g were anesthetized
with sodium pentobarbital (50 mg⁄kg, i.p.) and received sciatic nerve
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model). For the SCNT, the left sciatic nerve was transected at the
lower thigh level and a 5-mm portion of the nerve was resected to
prevent regeneration. For the PSNL, unilateral partial nerve ligation of
the sciatic nerve was performed as previously described (Ma &
Quirion, 2001). Brieﬂy, a tight ligature was made around the dorsal
half of the left sciatic nerve using 8-0 nylon such that half to a third of
the sciatic nerve was ligated. The wounds were then closed and the
rats were allowed to recover. At several time points (1, 3, 7, 14, 20 and
30 days) following the SCNT, groups of rats were processed for
histological analysis (n ¼ 4 at each time point). Every effort was made
to reduce the number of animals used. All animal experimental
procedures were approved by the Hyogo College of Medicine
Committee on Animal Research and were carried out in accordance
with the National Institutes of Health guidelines on animal care.
Intrathecal administration of anti-cell adhesion molecule
L1 antibody
After the SCNTand PSNL, the L6 vertebra was laminectomized and a
soft tube (Silascon, Kaneka Medix Company, Osaka, Japan; outer
diameter, 0.64 mm) ﬁlled with 5 lL of saline was inserted into the
subarachnoid space for a length of  0.5 cm. After the muscle incision
was closed, the mini-osmotic pumps (model 2001 or 2002, Alzet, CA,
USA) ﬁlled with non-immune mouse IgG (50 lg⁄mL) diluted by
saline, mouse monoclonal antibody against the L1-CAM extracellular
domain (R and D Systems Inc., MN, USA) or the p38 inhibitor
4-(4-ﬂuorophenyl)-2-(4-methylsulfonylphenyl)-5-(4-pyridyl)-1H-imi-
dazole (SB203580) (Calbiochem, La Jolla, CA, USA) were connected
to the tube. The concentrations of anti-L1-CAM antibody were 0.5, 5
and 50 lg⁄mL diluted in saline (n ¼ 6 for behavioral analysis and
n ¼ 4 for immunohistochemistry at each drug condition). The pump
was then laid under the skin and the incision was closed.
Reverse transcription-polymerase chain reaction
For the reverse transcription-polymerase chain reaction (PCR), the rats
were killed by decapitation under deep anesthesia with sodium
pentobarbital (50 mg/kg, i.p.) at 0, 3 and 14 days after surgery, and the
left L4,5 DRGs were removed and rapidly frozen with powdered dry
ice and stored at )80  C until ready for use (n ¼ 3 at each time point).
The procedure of extraction of total RNA using the RNA extraction
reagent ISOGEN (Nippon Gene, Tokyo, Japan) wasdescribed in our
previous study (Fukuoka et al., 2001). PCR primers for L1-CAM and
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) cDNA were
designed as follows: L1-CAM primers, sense 5¢-CCCCAGGTCAC-
CATTGGCTA-3¢ and antisense 5¢-CCCTAAGCCCCGCCCATTAA-
3¢; GAPDH primers, sense 5¢-TGCTGGTGCTGAGTATGTCG-3¢ and
antisense 5¢-GCATGTCAGATCCACAACGG-3¢.
The subsequent PCR reaction was performed in a 20-lL solution of
1· PCR buffer (PerkinElmer Life Sciences), 0.2 mm deoxyNTP and
1.25 U of AmpliTaq (PerkinElmer Life Sciences) with a pair of
10-pmol L1-CAM and GAPDH primers on a Perkin DNA Thermal
Cycler (PerkinElmer Life Sciences), and the PCR program was 15 s at
94  C, 15 s at 57  C and 45 s at 72  C (Obata et al., 2004b). The
intensity of stained bands was measured with a computer-assisted
imaging-analysis system (Densitograph, version 4.02; ATTO, Tokyo,
Japan). The density of PCR product bands of L1-CAM and GAPDH
mRNA was increased between 25 and 35 PCR cycles, depending on
the number of cycles; therefore, the number of PCR cycles used
was 30. The ratio of L1-CAM : GAPDH mRNA was considered to
indicate the level of each transcript. The mRNA level was expressed
as a percentage of the mRNA level in the normal control ganglia.
Samples without the addition of reverse transcriptase or without
the addition of RNA (negative controls) revealed no detectable
product.
In-situ hybridization
The protocol for in-situ hybridization (ISH) was described in detail
previously (Yamanaka et al., 2004). The clone (p-GEM T-easy,
Promega, MI, USA) containing a partial sequence corresponding to
the coding regions of L1-CAM (from 2495 to 2809, Gene bank
Accession no. X59149) was prepared and alpha-
35S UTP-labeled
antisense and sense cRNA probes were synthesized using the
enzyme-digested clones. The
35S-labeled probes in hybridization
buffer were placed on the tissue sections on slides. The sections were
incubated at 55  C overnight, then washed and treated with 1 lg⁄mL
RNase A. The sections were then air-dried. After the hybridization
reaction, the slides were coated with NTB-3 emulsion (Kodak,
Rochester, NY USA) and exposed for 2–5 weeks. Once developed in
D-19 (Kodak), the sections were stained with hematoxylin-eosin and
coverslipped.
Immunohistochemistry
Rats that received the SCNT or PSNL were used for immunohisto-
chemistry. These rats were deeply anesthetized with sodium pento-
barbital (70–80 mg⁄kg body weight, i.p.) and perfused transcardially
with 100 mL of 1% paraformaldehyde in 0.1 m phosphate buffer,
pH 7.4, followed by 500 mL of 4% paraformaldehyde in 0.1 m
phosphate buffer. The L5 DRGs and spinal cord were dissected out
and post-ﬁxed in the same ﬁxative for 4 h at 4  C, followed by
immersion in 30% sucrose in 0.1 m phosphate buffer at 4  C
overnight. The tissue was frozen in powdered dry ice and cut on a
cryostat at 25-lm thickness for the spinal cord and 4-lm thickness for
the DRGs. The sections were processed for immunohistochemistry
using the ABC method (Yamanaka et al., 2004).
The following antibodies were used: goat anti-L1-CAM polyclonal
antiserum (1 : 10 000, Santa Cruz Biotechnology, Santa Cruz, CA,
USA), rabbit anti-phospho-p38 MAPK (p-p38) polyclonal antiserum
(1 : 500, Cell Signaling Technology, Beverly, MA, USA) and rabbit
anti-phospho-extracellular signal-regulated kinase polyclonal anti-
serum (1 : 500, Cell Signaling Technology). Double or triple staining
of L1-CAM was performed with the following antibodies; rabbit anti-
glial ﬁbrillary acidic protein polyclonal antiserum (1 : 1000, DAKO,
Glostrup, Denmark), mouse anti-neuroﬁlament (NF)-200 monoclonal
antiserum (1 : 10 000, Sigma, St Louis, MO, USA), mouse anti-
synaptophysin monoclonal antiserum (1 : 5000, Chemicon, Temecula,
CA, USA), rabbit anti-activating transcription factor 3 (ATF3) poly-
clonal antiserum (1 : 1000, Santa Cruz Biotechnology), mouse anti-
microtubule-associated protein 2 (MAP2) monoclonal antiserum
(1 : 5000, Sigma) and mouse anti-growth-associated protein 43
(GAP-43) monoclonal antiserum (1 : 10 000, Sigma).
In brief, DRGs and spinal cord sections were incubated with a
mixture of two or three primary antibodies overnight at 4  C and
followed by a mixture of Alexa Fluoro 350, 488 or 594-conjugated
secondary antibodies (1 : 5000, Molecular Probes, Eugene, OR, USA)
overnight at 4  C. For double staining of L1-CAM with ATF3,
L1-CAM was visualized as black signals by 0.05% 3,3-diaminobenzi-
dine tetrahydrochloride (Sigma) containing 0.3% nickel sulfate and
0.01% hydrogen peroxidase and then ATF3 staining was visualized as
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nickel sulfate.
Western blot analysis
For the western blot analysis, the rats were killed by decapitation
under deep anesthesia with sodium pentobarbital (50 mg/kg, i.p.) at
0, 3 and 14 days after SCNT (n ¼ 3 at each time point) and the left
DRG and spinal cord were removed and rapidly frozen with
powdered dry ice. Frozen spinal cord was homogenized (Polytron
PT3000, Brinkmann) at 10% (w⁄v) in a modiﬁed buffer containing
20 mm Tris-HCl, pH 7.4, 10% sucrose and protease inhibitors
(protease inhibitor cocktail, 1 : 5000, Nakarai, Kyoto, Japan).
Homogenates were vortexed for 60 min with intervening cooling
and centrifuged for 60 min at 13 500g at 4  C to recover the
supernatant ﬂuid. Proteins were resolved using 10% sodium dodecyl
sulfate–polyacrylamide gel electrophoresis and 30 lg protein was
applied to each lane. After electrophoresis, proteins were transferred
onto a polyvinylidene diﬂuoride membrane (Immobilon-P, Millipore,
Bedford, MA, USA) in 125 mm Tris⁄960 mm glycine for 100 min
at 100 mA. Blots were blocked for 1 h in 10% fat-free milk in 0.1 m
Tris-buffered saline containing 0.05% Tween 20. Incubations with
primary antibodies were performed overnight at 4  C (polyclonal L1-
CAM, 1 : 5000; mouse anti-beta actin monoclonal antiserum,
1 : 10 000, Sigma). Secondary antibodies, IgG conjugated to alka-
line phosphatase, were incubated for 1 h at room temperature
(25  C). Signal was detected by chemiluminescence using the
Disodium 3-(4-methoxyspiro {1,2-dioxetene-3,2’-(5’-chloro) tricyclo
[3.3.1.1
3,7] decan}-4-yl) phenyl phosphate ready-to-use reagent
(Roche, Indianapolis, IN, USA). Films were scanned and quantiﬁed
using NIH image (version 1.61).
Quantiﬁcation
For quantiﬁcation of L1-CAM immunoreactivity in the spinal cord, 10
sections of the spinal cord were randomly selected from each rat
(n ¼ 4 for each group). The immunoreactive (ir) images in laminae
I–II were captured with a digital camera and the intensity was
measured by a computerized image-analysis system (NIH image,
version 1.61). In 256 gray-scale signal gradients, we considered signal
intensities above 192 as positive signals. For quantiﬁcation of
immunostaining in the DRGs (L1-CAM, p-p38 and phospho-
extracellular signal-regulated kinase), images were captured by digital
camera (for 3,3-diaminobenzidine tetrahydrochloride staining images)
and confocal microscopy (for ﬂuorescence images) from each rat
(n ¼ 4 for each group; a total of at least 500 neurons from each rat),
and the immunoreactivities and size of neurons were measured by a
computerized image-analysis system (NIH image, version 1.61). The
thresholds of gray level density were set such that only high-intensity
ir proﬁles were accurately discriminated from the low-level ir proﬁles.
Data were represented as mean ± SEM. Differences between groups
were compared using one-way anova followed by individual post-
hoc comparisons (Fisher’s PLSD).
The quantiﬁcation of ISH was performed as described previously
(Yamanaka et al., 2004). Measurements of the density of silver grains
over tissue proﬁles were performed using a computerized image-
analysis system (NIH image, version 1.61). Only neuronal proﬁles
that contained visible nuclei were used for the quantiﬁcation. At a
magniﬁcation of 200· and with bright-ﬁeld illumination, the upper
and lower thresholds of gray level density were set such that only
silver grains were accurately discriminated from the background in the
outlined cell or tissue proﬁle and read by the computer pixel-by-pixel.
Next, the area of discriminated pixels was measured and divided by
the area of the outlined proﬁle, giving a grain density for each cell or
tissue proﬁle. To reduce the risk of biased sampling of the data due to
the varying emulsion thickness, we used a signal-to-noise ratio for
each cell in each tissue. The signal-to-noise ratio of an individual
neuron and its cross-sectioned area that was acquired from the outlined
proﬁle was plotted. To distinguish cell size-speciﬁc changes, we
characterized the DRG neurons as small (< 600 lm
2), medium
(600–1200 lm
2) and large (> 1200 lm
2), according to their cross-
sectional area. As a stereological approach was not used in this study,
quantiﬁcation of the data may represent a biased estimate of the actual
numbers of neurons. At least 400 neurons from the L5 DRGs of each
rat were measured.
Photomicrographs
All images of ISH and immunohistochemistry with 3,3-diaminobenzi-
dine tetrahydrochloride staining were digitized with a DIAPHOT-300
microscope connected to a DXM-1200 digital camera (both Nikon,
Japan). Double- or triple-staining two-dimensional images were
acquired using a confocal laser scanning microscope (LSM 510
version 2.8; Carl Zeiss Microimaging, Inc., Germany) with the oil
Plan-Neofular 40· and 100· objective lens. We used photoshop 6.0
(Adobe Systems, Mountain View, CA, USA) to optimize the images
and to make all ﬁgures.
Behavioral tests
All PSNL rats were tested for mechanical allodynia and thermal
hyperalgesia of the plantar surface of the hindpaw 1 day before
surgery and 3, 7, 12, 16 and 21 days after surgery. Mechanical
allodynia was assessed with a dynamic plantar aesthesiometer (Ugo
Basile, Comerio, Italy), which is an automated von Frey-type system
(Kalmar et al., 2003; Lever et al., 2003). To measure mechanical
thresholds of the hindpaw, rats were placed in a plastic cage with a
wire mesh ﬂoor and allowed to acclimate for 15 min before each test
session. A paw-ﬂick response was elicited by applying an increasing
force (measured in grams) using a plastic ﬁlament (0.5 mm diameter)
focused on the middle of the plantar surface of the ipsilateral hindpaw.
The force applied was initially below the detection threshold, then
increased from 1 to 50 g in 1-g steps over 20 s, and was then held at
50 g for an additional 10 s. The rate of force increase was 2.5 g⁄s.
The force to elicit a reﬂex removal of the ipsilateral hindpaw was
monitored. This was deﬁned as the mean of three measurements made
at 5-min intervals.
Heat hyperalgesia was tested using the plantar test (7370, Ugo
Basile). A radiant heat source beneath a glass ﬂoor was aimed at the
plantar surface of the hindpaw. Three measurements of latency were
taken for each hindpaw in each test session. The hindpaws were tested
alternately, with intervals between consecutive tests of 5 min. The
three measurements of latency per side were averaged. An assistant,
who was unaware of the treatment group, performed all of the
behavioral experiments. Data are expressed as mean ± SEM. Differ-
ences in changes of values over time of each group were tested using
one-way anova, followed by individual post-hoc comparisons
(Fisher’s PLSD). Pairwise comparisons (Student’s t-test) were used
to assess the effect of the L1-CAM antibody on the basal mechanical
and thermal sensation. A difference was accepted as signiﬁcant if
P < 0.05.
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Peripheral nerve injury did not affect the transcription of cell
adhesion molecule L1 mRNA
Weusedsemiquantitativereversetranscription-PCRinordertoexamine
the effect of SCNTon the expression of L1-CAM mRNA in the DRGs.
There was no signiﬁcant change in the quantiﬁcation of the ampliﬁed
bands of L1-CAM mRNA after SCNT (n ¼ 3 at each time point,
Fig. 1A). Expression of L1-CAM mRNA at the cellular level was
examined by ISH (Fig. 1B). In the injured and naive DRGs, most
neurons expressed L1-CAM mRNA, and weak signals were also
observed in satellite cells and Schwann cells. Small- and medium-sized
DRG neurons expressed high-intensity signals for L1-CAM mRNA
(Fig.1BandC).TheexpressionofL1-CAMmRNAinDRGsat14 days
after SCNT was similar to the control (Fig. 1B). Quantiﬁcation of the
silver grains on neuronal somata revealed that there were no signiﬁcant
changesintheexpressionlevelsofL1-CAMmRNAbetweenthecontrol
and SCNT conditions in each size of DRG neurons (n ¼ 4, total 2099
and 2122 neurons for SCNTand control rats, respectively, Fig. 1C). We
performed two different exposure conditions for ISH development and
obtained similar results (data not shown). These results were consistent
with a previous report (Zhang et al., 2000).
Changes of cell adhesion molecule L1 immunostaining in the
dorsal root ganglia following sciatic nerve transection
Using anti-L1-CAM antibody, we examined the effect of peripheral
axotomy on the expression of L1-CAM protein in the DRGs. In the
normal lumbar DRGs, most of the L1-CAM-ir proﬁles were located in
the cytoplasm of a subpopulation of small neurons and axonal ﬁbers
(Fig. 2A). Although most of the L1-CAM-ir proﬁles in small neurons
were intensely stained, large neurons showed weak staining. This
result was consistent with a previous study (Haney et al., 1999).
SCNT led to a marked change in the location of L1-CAM-ir proﬁles in
the ipsilateral DRGs. L1-CAM-ir proﬁles formed distinct ring
structures around cell somata 14 days after SCNT (Fig. 2B). The
number of L1-CAM-positive ring structures was signiﬁcantly
Fig. 1. Expression of cell adhesion molecule L1 (L1-CAM) mRNA in L4,5 dorsal root ganglia (DRGs) after sciatic nerve transection. (A) The levels of L1-CAM
mRNA in the ipsilateral L4,5 DRGs were determined by the reverse transcription-polymerase chain reaction (PCR) technique. Gel panels show PCR products from
the L4,5 DRGs taken at 3 and 14 days after surgery. Right graph shows the mRNA levels of L1-CAM expressed as percentages of the mRNA level in the normal
control ganglia (mean ± SEM). N.S., not signiﬁcant compared with the naive control (P > 0.05; anova). (B) Dark-ﬁeld images of in-situ hybridization (ISH) show
L1-CAM mRNA in L5 DRGs of a control rat (left) and 14 days after sciatic nerve transection (SCNT) (right). Insets show highly magniﬁed pictures.
(C) Quantiﬁcation of mean signal density of ISH in each size population in DRG neurons of control rats (grey bars) and 14 days after SCNT (black bars)
(mean ± SEM; n ¼ 4, total 2099 neurons for SCNT, total 2122 neurons for control naive). N.S., not signiﬁcant compared with control (P > 0.05; Student’s t-test).
Scale bars: 250 lm (low magniﬁcation), 25 lm (insets). GAPDH, glyceraldehyde 3-phosphate dehydrogenase.
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then lasted for at least 30 days after SCNT (n ¼ 4, more than 2000
neurons at each time point, Fig. 2C). At 14 days after SCNT,
33.3 ± 1.6% of L5 DRG neurons were surrounded by L1-CAM-
positive ring structures. The size distribution analysis revealed that
L1-CAM-ir ring structures were located preferentially in small to
medium-sized DRG neurons. In the L1-CAM-ir ring structure-positive
neurons, 70.1 ± 4.6% were small (< 600 lm
2), 19.0 ± 2.5% were
medium (600–1200 lm
2) and 10.9 ± 2.7% were large (> 1200 lm
2)
neurons (n ¼ 4, total 2079 neurons).
In highly magniﬁed two-dimensional confocal ﬂuorescent images
(Fig. 2D), L1-CAM-ir proﬁles were observed in the cytoplasm that
appeared as dots in the control DRGs. These L1-CAM-ir dots were
mainly observed in DRG neurons that were intensely labeled for
L1-CAM. L1-CAM-ir ring structures were observed in the injured
DRGs (Fig. 2E); however, the L1-CAM-ir dots in the cytoplasmic
labeling were apparently reduced.
Characterization of cell adhesion molecule L1-immunoreactive
ring structures
To identify the cell types that expressed L1-CAM-ir ring structures, we
performed double immunostaining of L1-CAM with marker proteins
such as glial ﬁbrillary acidic protein (satellite cells) and ATF3 (injured
neurons) (Tsujino et al., 2000). NF-200 (myelinated neurons) and
p-p38 were examined by triple immunostaining for L1-CAM. We used
double labeling with L1-CAM and glial ﬁbrillary acidic protein, a glial
marker (Fig. 3A–D), to determine the location of L1-CAM-ir proﬁles
that formed ring structures. The majority of the L1-CAM-ir structures
were detected between glial ﬁbrillary acidic protein-positive portions
and neuronal somata. In Fig. 1, transcription of L1-CAM was mainly
detected in neurons and was at very low levels in satellite cells. Thus,
it was considered that the L1-CAM-ir rings were formed on the
surface of neuronal somata at day 7 after SCNT (Fig. 3D). Double
labeling with L1-CAM and ATF3, a marker of injured neurons,
showed that most L1-CAM-ir ring structures were located in ATF3-
labeled L5 DRG neurons in the nuclei at 7 days after SCNT (Fig. 3E).
Among L1-CAM-ir rings, 87.7 ± 0.9% of neurons were observed with
ATF3-ir nuclei and 68.1 ± 2.8% of ATF3-ir neurons formed L1-CAM-
ir rings (n ¼ 4, total of 2305 neurons). Thus, the L1-CAM-positive
ring structures were mainly formed on the somata of the injured DRG
neurons.
Triple staining with L1-CAM, NF-200 and p-p38 revealed a
characteristic expression pattern of the L1-CAM-ir ring structure
after SCNT. We found that 26.4 ± 3.5% of neurons with L1-CAM-ir
rings were located around NF-200-ir neurons and L1-CAM-ir rings
surrounded 23.4 ± 4.4% of NF-200-ir neurons (Fig. 3F, H and I). As
Fig. 2. Changes of cell adhesion molecule L1 (L1-CAM) protein expression and the formation of L1-CAM-immunoreactive (ir) ring structures in the dorsal root
ganglia (DRGs) after sciatic nerve transection. Photomicrographs show L1-CAM immunoreactivity in the DRGs of normal control (A) and 14 days after sciatic
nerve transection (SCNT) (B). (C) Time course of the formation of L1-CAM-ir ring structures after SCNT shown by the percentage of neurons with L1-CAM-ir
ring structures in the total L5 DRGs (mean ± SEM; each time point n ¼ 4, more than 500 total neurons from each rat). #P < 0.05 (anova) compared with naive
control (day 0). (D and E) Highly magniﬁed confocal two-dimensional images show disappearance of intracellular L1-CAM-ir proﬁles in DRG neuron and the
accumulation around the cytoplasm after SCNT. Control L5 DRG neuron (D) and 14 days after SCNT (E). Scale bars: A and B, 50 lm; D and E, 10 lm.
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myelinated A-ﬁbers, these data indicated that a majority of the L1-
CAM-ir ring structures were formed around C-ﬁber neurons. p38
MAPK is known to be activated in small DRG neurons after nerve
injury and may be involved in neuropathic pain (Jin et al., 2003;
Obata et al., 2004a,b). We observed a high incidence of colocali-
zation of L1-CAM and p-p38 at 7 days after SCNT (Fig. 3F, G and
I). The quantiﬁcation showed that 85.3 ± 0.9% of neurons with the
L1-CAM-ir ring structures were labeled for p-p38 and 63.9 ± 2.4%
of p-p38-ir neurons had L1-CAM-ir ring structures (n ¼ 4,
586 L1-CAM-ir ring neurons, 770 p-p38-ir neurons and 703 NF-200-ir
neurons).
Sciatic nerve transection induced post-transcriptional modiﬁca-
tion of cell adhesion molecule L1 in dorsal root ganglia
The expression of L1-CAM protein was conﬁrmed by western blot
analysis of DRGs using anti-c-terminal L1-CAM. We could detect
three bands: 220-kDa (full-length L1-CAM), 105–95-kDa and 80-kDa
(c-terminal fragments) proteins. In DRGs, the 105–95-kDa fragments
showed a high level of expression. Although the transcription of L1-
CAM mRNA did not change after SCNT (Fig. 1), protein levels in
DRGs were affected after peripheral nerve injury in DRGs (Fig. 4A,
n ¼ 3 at each time point). At 3 days after SCNT, the full-length band
(220 kDa) increased and continued to 14 days (Fig. 4B). The 105–95-
Fig. 3. Characterization of sciatic nerve transection (SCNT)-induced cell adhesion molecule L1 (L1-CAM)-immunoreactive (ir) ring structure in dorsal root ganglia
(DRGs). (A–D) Double staining of L1-CAM-ir proﬁles (red) with glial ﬁbrillary acidic protein (GFAP) (green), a marker of satellite cells and Schwann cells, in the
L5 DRGs 7 days after SCNT. (C and D) Merged images of L1-CAM-ir proﬁles and GFAP-ir staining. (D) Higher magniﬁcation image of C. Arrows indicate the
L1-CAM-ir proﬁles that are located in neuronal somata. (E) Double staining of L1-CAM (black) with activating transcription factor 3 (ATF3) (brown), a marker of
injured neurons, shows the L1-CAM-ir ring structures formed around injured DRG neurons. (F–I) Triple staining demonstrates heavy colocalization of L1-CAM
(red) with phospho-p38 MAPK (p-p38) (green) and not with NF-200 (purple), a marker for myelinated A ﬁbers in injured DRG neurons. Scale bars: A–C, 10 lm; D,
2.5 lm; E, 25 lm; F and G, 25 lm.
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fragment showed a signiﬁcant decrease at 14 days after SCNT
(Fig. 4C and D). Clearly, the fragmentation of L1-CAM is altered after
peripheral nerve injury.
Cell adhesion molecule L1 increased in the dorsal horn following
sciatic nerve transection
The alteration in the localization of L1-CAM immunoreactivity in the
dorsal horn was examined after peripheral nerve injury. L1-CAM
immunoreactivity in spinal cord was predominantly localized in
laminae I–II of the dorsal horn (Fig. 5A and B). In control naive rat,
the L1-CAM immunoreactivity was observed as ﬁber-like or small
button-like structures (Fig. 5B). This expression pattern was very
similar to the previous study (Munakata et al., 2003; Runyan et al.,
2005). SCNT increased the L1-CAM-ir proﬁles as the large button-
like structures and a substantial increase in the number and intensity of
L1-CAM-ir buttons were observed in the ipsilateral L4,5 dorsal horn
14 days after SCNT (Fig. 5C and E). The quantiﬁcation of the
L1-CAM-ir buttons revealed that the accumulation of L1-CAM in the
dorsal horn became signiﬁcant at 7 days after SCNT and kept the
increase at 20 days (n ¼ 4 at each time point). The intensity of the
L1-CAM-ir proﬁle on the contralateral side was stable and showed no
difference from the control section (Fig. 5E). The increased number of
L1-CAM-ir buttons was reduced afterwards and returned to the normal
level at 30 days after SCNT (Fig. 5D and E).
Characterization of sciatic nerve transection induced cell
adhesion molecule L1-immunoreactive buttons in dorsal horn
To examine the changes in SCNT-induced L1-CAM-ir buttons, we
performed double staining of L1-CAM with the markers synaptophy-
sin (pre-synaptic button) and MAP2 (dendrite of second order neuron).
SCNT-induced L1-CAM-ir buttons were heavily colocalized with
Fig. 4. Alteration of cell adhesion molecule L1 (L1-CAM) fragments in
dorsal root ganglia (DRGs) after sciatic nerve transection (SCNT). (A) West-
ern blot analysis indicates an increase in full-length L1-CAM levels and
decrease in 80-kDa fragment in DRGs. (B–D) Quantiﬁcation of the L1-CAM
protein levels in DRGs after SCNT. The quantiﬁed band length is listed above.
#P < 0.05 (anova) compared with naive control (day 0).
Fig. 5. Increases in cell adhesion molecule L1 (L1-CAM) immunoreactivity
in dorsal horn after sciatic nerve transection (SCNT). (A) Low-power mag-
niﬁcation images of L1-CAM in spinal cord. Higher magniﬁcation images of
the dorsal horn in a control naive rat (B), 14 days after SCNT (C) and 30 days
after SCNT (D). (C) Increased L1-CAM-immunoreactive (ir) proﬁles in
button-like structures. (E) Statistical quantiﬁcation shows the effect of SCNT
on the area of the L1-CAM-ir buttons per section (mean ± SEM; n ¼ 4).
#P < 0.05 (anova) compared with naive control (day 0). Solid bars: ipsilateral,
open bars: contralateral. Scale bars: A, 200 lm; B–D, 50 lm.
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basal constitutive expression of L1-CAM and a limited colocalization
with synaptophysin (Fig. 6D). Higher magniﬁcation confocal images
of double labeling with L1-CAM and MAP2 revealed that L1-CAM-ir
proﬁles were attached on MAP2-ir dendrites after SCNT (Fig. 6E–G).
In contrast to the SCNT, a very low level of double labeling with
L1-CAM and MAP2 was observed in the control naive rats, indicating
very little post-synaptic localization of L1-CAM in the control
situation (Fig. 6H).
Sciatic nerve transection induced proteolysis of cell adhesion
molecule L1 in dorsal horn
The post-transcriptional modiﬁcation of L1-CAM was examined in the
dorsal horn after SCNT. Western blot analysis was performed using
extracted protein from the dorsal half portion of the spinal cord
ipsilateral to the nerve injury. Three bands of L1-CAM protein were
observed in the dorsal horn (Fig. 7A). These fragments were
considered to be L1-CAM proteolysed by extracellular proteases
(Nayeem et al., 1999; Matsumoto-Miyai et al., 2003). In contrast to
the DRGs, the intensity of 105–95 kDa was weak in spinal cord.
Densitometric analysis of each band revealed that SCNT affected the
proteolysis of L1-CAM in spinal cord (n ¼ 3 at each time point); full-
length L1-CAM was decreased and the intensity of the 80-kDa band
was increased after SCNT (Fig. 7A, B and D). The 105–95-kDa band
intensity showed no changes after SCNT (Fig. 7A and C).
Co-localization of sciatic nerve transection induced
growth-associated protein 43 and cell adhesion molecule L1
in dorsal horn
As it was reported that peripheral nerve injury induced GAP-43 not
only in DRGs but also in laminae I–II of the spinal cord (Woolf et al.,
1990; Chong et al., 1994), and GAP-43 plays an essential role in nerve
regeneration with L1-CAM in vivo and in vitro (Meiri et al., 1998;
Zhang et al., 2005), we examined the colocalization of L1-CAM with
GAP-43. After nerve injury, GAP-43 was up-regulated in the
ipsilateral laminae I–II of dorsal horn (Fig. 8A and B). Low-power
magniﬁcation of double-labeling images of GAP-43 with L1-CAM
revealed that the up-regulation of GAP-43 was restricted within the
Fig. 6. Characterization of sciatic nerve transection (SCNT)-induced cell adhesion molecule L1 (L1-CAM)-immunoreactive (ir) button in dorsal horn. (A–C)
Double staining of L1-CAM (red) with synaptophysin (green), a marker of pre-synaptic buttons, at day 14 after injury shows the increase in L1-CAM-ir proﬁles in
synaptic terminals. (D) Merged image of L1-CAM and synaptophysin in the dorsal horn of control rat. (E–G) Double staining of L1-CAM (red) with microtubule-
associated protein 2 (MAP2) (green), a marker of dendrite of central nervous system neuron, at day 14 after SCNT demonstrates L1-CAM accumulation in post-
synaptic areas. (H) Merged images of the dorsal horn of control rat. Scale bars: A–D, 10 lm; E–H, 5 lm.
Fig. 7. Proteolysis of cell adhesion molecule L1 (L1-CAM) in the spinal cord
after sciatic nerve transection (SCNT). (A) Western blot analysis indicates a
decrease in full-length L1-CAM levels and an increase in 80-kDa fragment in
dorsal root ganglia (DRGs) after SCNT. (B–D) Quantiﬁcation of the L1-CAM
protein levels in DRGs after SCNT (mean ± SEM; n ¼ 3 at each time point).
The quantiﬁed band lengths are listed above.
#P < 0.05 (anova) compared
with naive control (day 0).
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image, most GAP-43 immunoreactivity was observed in the synaptic
buttons that expressed L1-CAM (Fig. 8E–G).
Effects of anti-cell adhesion molecule L1 antibody on the
formation of cell adhesion molecule L1-immunoreactive ring
structures and the activation of p38 MAPK
We have shown that SCNT affected L1-CAM protein expression in
DRGs and the dorsal horn synapse and, moreover, the proteolysis of
the extracellular domain of L1-CAM (Figs 2, 4, 5 and 7). Next, we
examined the effects of intrathecal injection of antibody against the
L1-CAM extracellular domain in order to inhibit extracellular
interaction of L1-CAM after SCNT. Anti-L1-CAM antibody
(600 ng⁄day) was administrated intrathecally for 5 days in the SCNT
model rats (n ¼ 4 for each group). We examined the effect of the
antibody treatment on the formation of L1-CAM-ir ring structures in
DRGs. In control IgG- (600 ng⁄day) treated rats, the L1-CAM-ir ring
structures (visualized by antibody against c-terminal intracellular
domain) were signiﬁcantly increased at 7 days after SCNT when
compared with the control naive DRGs (Fig. 9A and B). Anti-L1-
CAM extracellular domain antibody treatment signiﬁcantly sup-
pressed the formation of L1-CAM-ir ring structures in the DRGs
(Fig. 9C and D). In the dorsal horn, the increase of L1-CAM-ir buttons
was not affected by the anti-L1-CAM antibody treatment (data not
shown).
Next, we examined the effect of anti-L1-CAM antibody on the
activation of p38 MAPK in the DRGs. Low levels of p-p38-ir
neurons were observed (18.9 ± 1.6% of DRG neurons) in control
naive DRGs (Fig. 9E and H). In the control IgG- (600 ng⁄day)
treated rats, SCNT activated p38 MAPK in a subpopulation of DRG
neurons (41.0 ± 2.7% of L5 DRG neurons) at 7 days after injury
(Fig. 9F and H). Anti-L1-CAM antibody (600 ng⁄day) administrated
intrathecally by osmotic pump signiﬁcantly decreased p-p38-ir
neurons in the DRGs at 7 days after injury (Fig. 9G and H)
(26.7 ± 2.8% of L5 DRG neurons, P < 0.01). In contrast to the
effect on p38 MAPK activation, administration of anti-L1-CAM
antibody had no effect on the phosphorylation of extracellular signal-
regulated kinase after SCNT. Activation of extracellular signal-
regulated kinase in satellite cells and large diameter neurons in the
DRGs by peripheral nerve injury was increased compared with naive
control (Fig. 9I and J) and intrathecal administration of anti-L1-CAM
antibody did not reduce the increase of phospho-extracellular signal-
regulated kinase (Fig. 9K and L).
P38 activation did not affect the formation of cell adhesion
molecule L1-immunoreactive ring structures in injured dorsal
root ganglia
To investigate the contribution of p38 activation to the formation of
L1-CAM-ir ring structures, we intrathecally administered the p38
inhibitor SB203580 for 5 days in the SCNT model rats (n ¼ 4 for
each group). The dose of SB203580 was adjusted as in the previous
report (4 lg⁄day, Jin et al., 2003). SCNT induced ring structures of
L1-CAM immunoreactivity in both the control IgG and SB203580-
treated DRG sections (Fig. 10A and B). Quantiﬁcation of the
L1-CAM-ir ring structures revealed that the SB203580 treatment
had no effect on the formation of L1-CAM-ir ring structures after
SCNT (P > 0.05, Fig. 10C).
Changes of cell adhesion molecule L1 expression and behavi-
oral hypersensitivity in the neuropathic pain model rats
In PSNL rats that showed pain behaviors, L1-CAM-ir ring structures
were exclusively observed in ATF3-ir injured DRG neurons
Fig. 8. Double-labeling confocal two-dimensional images of growth-associated protein 43 (GAP-43) (green) and cell adhesion molecule L1 (L1-CAM) (red)i n
dorsal horn 14 days after sciatic nerve transection (SCNT). (A and B) GAP-43 increased in laminae I–II of the dorsal horn and colocalized with L1-CAM.
(A) Contralateral and (B) ipsilateral to the SCNT. (C) L1-CAM immunoreactivity and (D) a merged image of B and C. (E–G) Higher magniﬁcation images of
double labeling show colocalization with GAP-43- (E) and L1-CAM-immunoreactive buttons (F). (G) A merged image of E and F. Scale bars: A–D, 100 lm;
E–G, 10 lm.
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dorsal horn of the PSNL rats (Fig. 11B). We knew that PSNL, a
neuropathic pain model, showed a very similar alteration in L1-CAM
expression in DRGs and spinal dorsal horn. In order to investigate
whether the alteration of L1-CAM expression is involved in the
alteration of nociception and development of neuropathic pain, we
examined the effect of intrathecal administration of anti-L1-CAM
antibody on the pain behaviors (n ¼ 6 for each group). PSNL induced
a mechanical allodynia that was present on day 3 after surgery and
was maintained for several weeks. We administrated the antibody from
day 3 to day 16. The highest dose of anti-L1-CAM antibody
administration (600 ng⁄day) reversed injury-induced mechanical
allodynia from day 7 to day 21 after injury (Fig. 11D). In groups
with lower concentrations of L1-CAM antibody (60 and 6 ng⁄day),
the signiﬁcant reduction was observed at 12 and 16 days after injury
(Fig. 11D).
Thermal sensitivity was also examined in these animals. PSNL-
induced thermal hyperalgesia was attenuated by intrathecal adminis-
tration of anti-L1-CAM antibody. Thermal hyperalgesia was reversed
from day 7 to day 21 after injury when the highest dose was
administered (600 ng⁄day). In lower concentration groups (60 and
6n g⁄day), suppression of the thermal hyperalgesia was greater than
that of mechanical allodynia. The inhibition of thermal hyperalgesia
produced by the low doses of L1-CAM antibody was observed from
day 7 to day 16 (Fig. 11F). In sham-operated rats, the basal
mechanical and thermal sensitivity was not affected by the anti-L1-
CAM antibody and did not show any difference from the IgG
treatment (Fig. 11E and G). The IgG treatment itself did not show any
effect.
Anti-cell adhesion molecule L1 antibody reduced cell adhesion
molecule L1-immunoreactive ring structures in neuropathic pain
model dorsal root ganglia
We conﬁrmed that the anti-L1-CAM antibody treatment inhibited the
formation of L1-CAM-ir ring structures in PSNL model DRGs. The
expression of L1-CAM was examined following intrathecal adminis-
tration of anti-L1-CAM antibody or control IgG for 5 days
(600 ng⁄day) in the PSNL model rats (n ¼ 4 for each group). Anti-
L1-CAM antibody and IgG were administrated from day 2 after
injury. The result was similar to the SCNT model. In the control IgG-
treated DRGs, a substantial increase of L1-CAM-ir ring structures was
observed (Fig. 12A). Intrathecal L1-CAM antibody administration
signiﬁcantly reduced the increase of L1-CAM-ir ring structures
(Fig. 12B and C).
Fig. 9. Effects of the anti-cell adhesion molecule L1 (L1-CAM) antibody on sciatic nerve transection (SCNT)-induced alteration of L1-CAM and phosphorylation
of MAPKs in the dorsal root ganglia (DRGs). Photomicrographs show the expression of L1-CAM-immunoreactive (ir) ring structure (A–C), phosphorylated p38-ir
proﬁles (E–G) and phosphorylated extracellular signal-regulated kinase (p-ERK)-ir proﬁles (I–K). Tissue sections are L5 DRGs of a control naive rat (A, E and I),
7 days after SCNT treatment with intrathecal control IgG (B, F and J) and 7 days after SCNT treatment with intrathecal chronic injection of anti-L1-CAM antibody
(600 ng ⁄ day) (C, G and K). Quantiﬁcation of the percentage of neurons with L1-CAM-ir ring structures (D), phospho-p38 MAPK (p-p38)-ir neurons
(H) and p-ERK-ir neurons (L) at 7 days after SCNT (mean ± SEM; n ¼ 4, more than 500 total neurons from each rat) (Ab, antibody). P < 0.05 compared with
saline-treated group (anova); NS, not signiﬁcant (P > 0.05);
#P < 0.05 (anova) compared with naive control. Scale bars: A–C and E–G, 50 lm; I–K, 100 lm.
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European Journal of Neuroscience, 25, 1097–1111Fig. 11. Changes of cell adhesion molecule L1 (L1-CAM) protein expression and pain behaviors in neuropathic pain model. (A–C) Expression of L1-CAM in
dorsal root ganglia (DRGs) and dorsal horn of partial sciatic nerve transection (PSNL) rats at 14 days after injury. (A) Double labeling of L1-CAM with activating
transcription factor 3 in DRGs at 14 days after PSNL. (B and C) PSNL induced L1-CAM-immunoreactive buttons in dorsal horn. Dorsal horn ipsilateral
(B) and contralateral (C) to the PSNL. Scale bar: A–C, 25 lm. (D–G) Effects of intrathecal chronic administration of anti-L1-CAM antibody on neuropathic pain
behaviors. (D) The effects of chronic intrathecal administration of anti-L1-CAM antibody on mechanical allodynia in the PSNL model. The highest concentration
of anti-L1-CAM antibody (600 ng ⁄ day) administration reversed the thermal hyperalgesia for up to 21 days after surgery. The lower concentrations of L1-CAM
(60 and 6 ng ⁄ day) had a limited effect on the withdrawal threshold, except at day 16 after injury. (F) The withdrawal latency to the radiant heat stimuli was
obtained from the same rats that received the mechanical stimuli. Injury-induced thermal hyperalgesia was suppressed by the administration of the L1-CAM
antibody. (E and G) Intrathecal anti-L1-CAM antibody and control IgG have no effects on the basal mechanical and thermal sensitivity. *P < 0.05 compared with
saline-treated group. In all graphs, values were represented by mean ± SEM (n ¼ 6 in each group) (Ab, antibody).
Fig. 10. Effects of the p38 inhibitor 4-(4-ﬂuorophenyl)-2-(4-methylsulfonylphenyl)-5-(4-pyridyl)-1H-imidazole (SB) on the formation of cell adhesion molecule
L1 (L1-CAM)-immunoreactive (ir) ring structures in the dorsal root ganglia (DRGs) following sciatic nerve transection (SCNT). Tissue sections are L5 DRGs of
7 days after SCNT treatment with intrathecal control vehicle (A) and 7 days after SCNT treatment with intrathecal chronic injection of SB (4 lg ⁄ day)
(B). (C) Quantiﬁcation of the percentage of neurons with L1-CAM-ir ring structures (mean ± SEM; n ¼ 4, more than 500 total neurons from each rat). NS, not
signiﬁcant (P > 0.05, Student’s t-test). Scale bar, 50 lm.
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Changes of cell adhesion molecule L1 expression in injured
dorsal root ganglia neurons
CelladhesionmoleculeL1hasbeenshowntoexistinthecontactsurface
of injured peripheral axons and wrapping Schwann cells and suggested
tobeinvolvedintheregeneration process(Martini &Schachner,1988).
The trans-homophilic interaction of L1-CAM may directly promote
neurite outgrowth in vitro (Lemmon et al., 1989; Doherty et al., 1995).
Inthesestudies,L1-CAMwasthoughttoactatthesiteofregenerationor
in neurite elongation. We conﬁrmed that SCNT did not affect the
transcription of L1-CAM mRNA and L1-CAM immunoreactivity in
cytoplasm was reduced in injured DRG neurons. Therefore, we
considered that the appearance of the L1-CAM-ir ring is due to the
changes of protein sorting following nerve injury. Accumulated L1-
CAM in the cell surface could mediate extracellular signals into the cell
body in which the neuronal somata do not receive direct injury.
Furthermore, we could show that the peripheral axotomy increased the
full-lengthL1-CAManddecreasedthefragmentsofL1-CAMinDRGs.
Therefore, the full-length L1-CAM may accumulate in the surface of
somata of DRG neurons after nerve injury. In the present study, it is not
clear whether the accumulation of L1-CAM was located only on the
neuronal surface or in both neurons and satellite cells after nerve injury.
L1-CAM that accumulated in somata might serve as the ligand binding
to satellite cells or extracellular matrix.
Previous studies have suggested that neuron–satellite cell commu-
nication is mediated by soluble⁄diffuse factors such as nerve growth
factor, nitric oxide or adenosine triphosphate (Aoki et al., 1993; Zhou
et al., 1999; Weick et al., 2003; Hanani, 2005). It is known that the
damage to peripheral nerves induces satellite cells to promote the
neuron–satellite cell interaction and this process between neuron and
glial cells has a role in pathological changes in the DRGs after
neuropathic injury (Hanani, 2005). Post-transcriptional regulation of
L1-CAM, such as the accumulation in neuronal somata and increase of
full-length L1-CAM shown in the present study, may be involved in
this pathophysiology within DRGs.
Increase of cell adhesion molecule L1 in the dorsal horn after
peripheral nerve injury
We showed here that peripheral nerve injury resulted in an increase of
L1-CAM mainly in pre-synaptic synapses in the dorsal horn along
with the DRGs. When compared with the changes in the DRGs, the
increase of synaptic L1-CAM was delayed in time course and
occurred after only a short period following nerve injury (7–20 days).
L1-CAM was thought to be involved in synaptic plasticity in the
hippocampus (Luthl et al., 1994; Matsumoto-Miyai et al., 2003;
Saghatelyan et al., 2004). In mouse brain, a proteomic analysis of
N-methyl-d-aspartate receptor revealed the molecular link of L1-CAM
and N-methyl-d-aspartate receptor, and the receptor–adhesion mole-
cule complex was bound to signaling molecules that lead to the
MAPK pathway (Husi et al., 2000). N-methyl-d-aspartate receptor in
the dorsal horn is considered to be one of the key molecules involved
in neuropathic pain (Seltzer et al., 1991; Baba et al., 2000). Thus,
alterations in L1-CAM in dorsal horn synapses may be involved in the
N-methyl-d-aspartate receptor activity after peripheral nerve injury.
In dorsal horn synapses, the appearance of pre-synaptic L1-CAM
suggests that peripheral nerve injury can affect the dorsal horn neurons
by modulating L1-CAM signaling or by dorsal horn circuitry changes
mediated byL1-CAM. Western blotanalysisshowedtheincrease of the
80-kDa fragment, which may be a product of the cleavage of L1-CAM
byplasmin(Nayeemetal.,1999).Ourpreviousstudydemonstratedthat
the peripheral nerve injury increased the proteolytic activity of tissue-
type plasminogen activator in dorsal horn (Yamanaka et al., 2004).
Therefore, peripheral nerve injury can activate the tissue-type plasmi-
nogen activator-plasminogen system and this might be a mechanism of
cleavageofL1-CAMandincreased80-kDafragmentinthedorsalhorn.
Recent studies suggest an interesting hypothesis that the fragment
of L1-CAM affects the neuronal activity in vivo; the proteolysis of
L1-CAM is involved not only in the synaptic plasticity (Matsumoto-
Miyai et al., 2003) but also in the neurite outgrowth (Nayeem et al.,
1999; Maretzky et al., 2005). In the present study, we conﬁrmed the
colocalization of L1-CAM and GAP-43 that is known as a marker for
structural plasticity in the central nervous system (Benowitz et al.,
1990; Masliah et al., 1991; Li et al., 1998). GAP-43 is known to act
synergistically with L1-CAM in neurite outgrowth or regeneration
(Meiri et al., 1998; Zhang et al., 2005). Moreover, SCNT rapidly
decreased pre-synapse E-cadherin in the dorsal horn (Brock et al.,
2004). Collectively, the increase of L1-CAM and reduction of
E-cadherin in dorsal horn synapses support the idea that the synaptic
reorganization is mediated by the alteration of adhesion molecules
after peripheral nerve injury.
Effects of the antibody for cell adhesion molecule L1 on MAPK
activation in the dorsal root ganglia and behavioral
hypersensitivity
Most L1-CAM-ir ring structures were formed around ATF3-ir
neurons, indicating that the emergence of cell surface accumulation
Fig. 12. Effects of the anti-cell adhesion molecule L1 (L1-CAM) antibody on partial sciatic nerve transection (PSNL)-induced alteration of L1-CAM in the dorsal
root ganglia (DRGs). Tissue sections are L5 DRGs of 7 days after PSNL treatment with intrathecal control IgG (A) and 7 days after PSNL treatment with
intrathecal chronic injection of anti-L1-CAM antibody (600 ng ⁄ day) (B). (C) Quantiﬁcation of the percentage of neurons with L1-CAM-immunoreactive (ir) ring
structures (mean ± SEM; n ¼ 4, more than 500 total neurons from each rat). P < 0.05 compared with control IgG-treated group (Student’s t-test). Left bar: IgG
treatment, right bar: L1-CAM antibody treatment. Scale bar, 50 lm.
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of L1-CAM by intrathecal administration of the anti-L1-CAM
antibody reduced the L1-CAM-ir ring structure in the DRGs after
injury. This suggests that the anti-L1-CAM antibody can inhibit the
accumulation of L1-CAM on the cell membrane of neuronal somata
and possibly inhibit interaction with satellite cells. In previous reports,
anti-L1-CAM antibody was used to inhibit L1-CAM binding, and the
blocking of L1-CAM binding suppressed physiologically signiﬁcant
events such as neurite extension, Schwann cell ensheathment, long-
term potentiation and remodeling of lymph node reticular matrix
during immune response (Seilheimer & Schachner, 1988; Seilheimer
et al., 1989; Luthl et al., 1994; Di Sciullo et al., 1998). Thus, we
believe that the effects of the anti-L1-CAM antibody shown in the
present study are the result of L1-CAM binding inhibition in the
nociceptive pathways. The mechanism of how the antibody treatment
reduced the accumulation of L1-CAM on the cell surface needs further
study. It may be due to the internalization of accumulated L1-CAM by
the antibody binding as demonstrated in vitro (Schmid et al., 2000).
We also demonstrated that the intrathecal injection of the anti-L1-
CAM antibody reduced activation of p38 MAPK but not phospho-
extracellular signal-regulated kinase in the injured DRGs. We
previously reported that SCNT activated extracellular signal-regulated
kinase in large diameter neurons and satellite cell in DRGs (Obata
et al., 2003). These cells do not seem to colocalize with L1-CAM-ir
ring structures in DRGs. In-vitro studies demonstrate that L1-CAM
can activate extracellular signal-regulated kinase (Doherty et al.,
2000). The discrepancy of these results is not clear at this point. The
reduction of activated p38 MAPK by the anti-L1-CAM antibody
treatment is intriguing because p-p38 was induced in DRG neurons
after nerve injury and is thought to be one of the factors responsible
for neuropathic pain (Jin et al., 2003; Obata et al., 2004a,b). The
ﬁnding that inhibition of L1-CAM results in a reduction of both the
cell surface accumulation of L1-CAM and the activation of p38
MAPK suggested a possible interaction between L1-CAM accumu-
lation and activation of p38 MAPK. There are two major L1-CAM
signaling pathways, the ﬁbroblast growth factor receptor 1–phospho-
lipase C gamma-mediated pathway (Doherty et al., 1995; Meiri et al.,
1998) and the src-dependent MAPK pathway (Schmid et al., 2000).
There have been no reports showing that these ﬁbroblast growth factor
receptor 1 and src-signaling cascades can activate p38 MAPK in the
DRGs. The present data indicate that the extracellular interaction by
L1-CAM in injured neurons may activate intracellular signaling
cascades such as p38 MAPK and affect the neuroplastic changes in the
DRGs and spinal dorsal horn, resulting in the pain hypersensitivity in
neuropathic conditions.
In order to determine the effect of the alteration of L1-CAM on pain
behaviors, we intrathecally injected an antibody for the L1-CAM
extracellular domain. Although the anti-L1-CAM antibody did not
affect basal pain sensitivity, both mechanical and thermal hyperalgesia
were signiﬁcantly suppressed in a dose-dependent manner from
4 days after initiation of antibody administration until 1 week after the
termination of the administration. At the doses that we used, we did
not ﬁnd obvious toxicity of this antibody, animals behaved normally
and locomotion was unaffected. These data suggest that the suppres-
sion of L1-CAM binding by antibody administration can affect the
pain hypersensitivity in a partial nerve injury model and the alteration
in L1-CAM in primary afferents is involved in the development of
neuropathic pain. The intrathecal antibody could not suppress the
increase of L1-CAM-ir buttons in the dorsal horn. The facts that the
infused antibody is for the extracellular domain and the increased
button consists of mainly proteolytic fragments of L1-CAM could be
one reason for the ineffectiveness. However, we cannot exclude a
possible role of L1-CAM changes in the dorsal horn on pain behaviors
in the neuropathic pain model. The accumulation of the L1-CAM in
neural somata and synapses may mediate cell–cell interaction and the
communication of neurons and satellite cells. The possible involve-
ment of L1-CAM in the activation of p38 MAPK and synaptic
reorganization represents a novel form of modulation of nociceptive
pathways.
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